1. Home
  2. CELU vs PED Comparison

CELU vs PED Comparison

Compare CELU & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • PED
  • Stock Information
  • Founded
  • CELU 2016
  • PED N/A
  • Country
  • CELU United States
  • PED United States
  • Employees
  • CELU N/A
  • PED N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • PED Oil & Gas Production
  • Sector
  • CELU Health Care
  • PED Energy
  • Exchange
  • CELU Nasdaq
  • PED Nasdaq
  • Market Cap
  • CELU 42.2M
  • PED 48.8M
  • IPO Year
  • CELU N/A
  • PED N/A
  • Fundamental
  • Price
  • CELU $2.00
  • PED $0.64
  • Analyst Decision
  • CELU
  • PED Strong Buy
  • Analyst Count
  • CELU 0
  • PED 2
  • Target Price
  • CELU N/A
  • PED $1.63
  • AVG Volume (30 Days)
  • CELU 75.7K
  • PED 572.7K
  • Earning Date
  • CELU 05-08-2025
  • PED 08-13-2025
  • Dividend Yield
  • CELU N/A
  • PED N/A
  • EPS Growth
  • CELU N/A
  • PED 2248.88
  • EPS
  • CELU N/A
  • PED 0.19
  • Revenue
  • CELU $54,220,000.00
  • PED $40,173,000.00
  • Revenue This Year
  • CELU $23.29
  • PED N/A
  • Revenue Next Year
  • CELU N/A
  • PED $5.99
  • P/E Ratio
  • CELU N/A
  • PED $3.36
  • Revenue Growth
  • CELU 138.11
  • PED 30.70
  • 52 Week Low
  • CELU $1.00
  • PED $0.47
  • 52 Week High
  • CELU $5.22
  • PED $1.10
  • Technical
  • Relative Strength Index (RSI)
  • CELU 51.94
  • PED 51.04
  • Support Level
  • CELU $1.80
  • PED $0.63
  • Resistance Level
  • CELU $2.26
  • PED $0.67
  • Average True Range (ATR)
  • CELU 0.18
  • PED 0.05
  • MACD
  • CELU 0.02
  • PED -0.01
  • Stochastic Oscillator
  • CELU 48.25
  • PED 22.62

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

Share on Social Networks: